Position, Reporting and Duties. While serving as the Company’s Interim Chief Executive Officer, Executive shall report to the Board, shall have such duties, authority, and responsibilities as are customary for such position in a Delaware corporation (subject to the control of the Board and its committees), and shall perform such other duties as may be reasonably requested by the Board, including without limitation assisting the Board in the hiring of a permanent Chief Executive Officer for the Company. Executive shall devote substantially all of Executive’s working time and efforts to the business and affairs of the Company (which shall include service to its “Affiliates” (within the meaning of Rule 12b-2 promulgated under Section 12 of the Exchange Act)), provided that (i) Executive shall be permitted to manage Executive’s personal, financial and legal affairs, subject to compliance with this Agreement and (ii) Executive shall be permitted to serve on the board of directors of up to two (2) publicly traded or privately held companies. Executive agrees to observe and comply with the rules and policies of the Company and its Affiliates as adopted by the Company or its Affiliates from time to time, in each case as amended from time to time, as set forth in writing, and as delivered or made available to Executive (each, a “Policy”).
Position, Reporting and Duties. While serving on an interim basis as the Company’s Chief Executive Officer, the Executive will report to the Board, shall have such duties, authority, and responsibilities as are customary with such position in a Delaware corporation (subject to the control of the Board and its committees), and shall perform such other duties as may be reasonably requested by the Board, including without limitation assisting the Board in the hiring of a new chief executive officer for the Company. The Executive shall devote his full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the Board. Notwithstanding the foregoing, the Board hereby acknowledges and approves the Executive’s continued participation as a director of all companies on which the Executive is serving as a member of the board of directors as of the Commencement Date, and the Executive may serve in religious or charitable activities, and/or may continue in other professional activities in which the Executive is engaged as of the Commencement Date and of which the Company is aware, as long as such services and activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. It is anticipated that the Executive will primarily work remotely from his home in Michigan or Florida, unless the Executive is traveling to Blacksburg, VA or otherwise on behalf of the Company. The Executive shall also be required to comply with all Company policies and procedures as in effect from time to time.
Position, Reporting and Duties. The Executive will serve as the Company’s Chief Medical Officer, reporting to the Company’s President & Chief Executive Officer (“CEO”). The Executive agrees to abide by the rules, regulations, instructions, personnel practices and policies of the Company and any changes therein that may be adopted from time to time by the Company. The Executive’s normal place of work will be in the Company’s Lexington, Massachusetts offices, unless the Executive is traveling on behalf of the Company. The Executive shall devote the Executive’s full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the CEO and provided that such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company.
Position, Reporting and Duties. The Company and Executive acknowledge and agree that: (a) commencing on the November 29, 2018, the Executive served as the Vice President of Research of the Company, reporting to the Company’s Chief Scientific Officer; (b) commencing on August 20, 2021, the Executive served as Vice President of Research, reporting to the Company’s Chief Scientific Officer; (c) commencing on March 14, 2022, the Executive served as Senior Vice President of Research, reporting to the Company’s Chief Scientific Officer, and (d) commencing on September 19, 2022, the Executive will serve as Chief Scientific Officer, reporting to the Company’s President and Chief Executive Officer (“CEO”). The Executive shall devote the Executive’s full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the CEO and provided that such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. The Executive’s normal place of work will be Cambridge, MA. It is understood and agreed that the Executive will generally be on site in Cambridge, unless the Executive is traveling on behalf of the Company.
Position, Reporting and Duties. The Executive will report to the Company’s Chief Executive Officer and the Board and will serve on an interim basis as the Chief Scientific Officer of the Company, with the traditional power and duties of such office in companies of similar size to the Company and carrying out such additional executive level duties as may be reasonably assigned by the Board. The Executive shall devote fifty percent (50%) of the Executive’s working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the Board and provided that such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. Notwithstanding the foregoing, the Board hereby acknowledges and approves the Executive’s continued participation as a director of all companies on which the Executive is serving as a member of the board of directors as of the Effective Date, and the Executive may serve in religious or charitable activities, and/or may continue in other professional activities in which the Executive is engaged as of the Effective Date and of which the Company is aware, as long as such services and activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. The Executive will normally work remotely from his home in California, unless the Executive is traveling to Cambridge, MA or otherwise on behalf of the Company.
Position, Reporting and Duties. The Company and Executive acknowledge and agree that commencing on the Effective Date, the Executive will serve as Vice President of Finance, reporting to the Company’s Chief Financial Officer (the “CFO”). The Executive shall devote the Executive’s full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the CFO and provided that such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. The Executive’s normal place of work will be Cambridge, MA. It is understood and agreed that the Executive will generally be on site in Cambridge, unless the Executive is traveling on behalf of the Company.
Position, Reporting and Duties. The Executive will serve as the Chief Medical Officer and Head of Research & Development of the Company, reporting to the Company’s President and Chief Executive Officer (“CEO”), and will serve as and be considered a “C-Level” executive officer, exercising the traditional power and duties of such office in companies of similar size to the Company and carrying out such additional executive level duties as may be reasonably assigned by the CEO. The Executive shall devote the Executive’s full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the CEO and provided that such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. Beginning on the Commencement Date, and through no later than October 31, 2019, the Executive will be permitted to work remotely from Switzerland. Beginning no later than November 1, 2019, the Executive’s normal place of work will be Cambridge, MA. It is understood and agreed that, as soon as he is eligible to work in the United States (but in no event later than November 1, 2019), the Executive will generally be on site in Cambridge, unless the Executive is traveling on behalf of the Company, or while traveling in the initial transition period during family relocation from Basel.
Position, Reporting and Duties. The Executive will serve as Chief Financial Officer, reporting to the Company’s President and Chief Officer (“CEO”). The Executive shall devote the Executive’s full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities with for-profit entities, including service as a member of a board of directors or other similar governance body, provided Executive may engage in business activities with for-profit entities if such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company, and such activities have been pre-approved in writing by the CEO. Executive may serve on the boards of directors of non-profit entities engaged in religious, charitable and community-oriented objectives, provided that such service does not compete with the Company does not violate the Company’s standards of conduct then in effect and does not raise a conflict under the Company’s conflict of interest policies. The Executive’s normal place of work will be in the Company’s Cambridge and Lexington, MA offices according to the Company’s current policy regarding workplace attendance. It is understood and agreed that the Executive will generally be on site in Cambridge and Lexington not less than three days per week, unless the Executive is traveling on behalf of the Company. The Executive agrees to abide by the rules, regulations, instructions, personnel practices and policies of the Company and any changes therein that may be adopted from time to time by the Company.
Position, Reporting and Duties. The Executive will serve as the President and Chief Executive Officer of the Company with the traditional power and duties of such office in companies similar in size to the Company and such additional other executive level duties reasonably assigned by the Company’s Board of Directors (the “Board”). The Executive shall continue to serve on the Board following his commencement as the Company’s
Position, Reporting and Duties. The Company and the Executive agree as follows: (a) commencing on the Commencement Date, the Executive served as the Senior Vice President, Portfolio Management and Patient Engagement of the Company, reporting to the Company’s President and Chief Executive Officer (the “CEO”); (b) commencing on August 9, 2021, the Executive served as the Senior Vice President, Business Operations of the Company, reporting to the CEO; and (c) commencing on the Effective Date, the Executive will serve as the Chief Operating Officer of the Company, reporting to the CEO. The Executive shall devote the Executive’s full working time and efforts to the business and affairs of the Company and shall not engage in any other business activities without the prior written approval of the CEO and provided that such activities do not create a conflict of interest or otherwise interfere with the Executive’s performance of the Executive’s duties to the Company. The Executive’s normal places of work will be Cambridge, MA and Lexington, MA. It is understood and agreed that the Executive will generally be on site in Cambridge or Lexington, unless the Executive is traveling on behalf of the Company.
